Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred StockGlobeNewsWire • 03/03/21
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021GlobeNewsWire • 03/01/21
Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion PlanGlobeNewsWire • 02/22/21
Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA FilingBusiness Wire • 02/03/21
Avid Bioservices' (CDMO) CEO Nick Green on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 12/03/20
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent DevelopmentsGlobeNewsWire • 12/02/20
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020GlobeNewsWire • 11/24/20
Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020GlobeNewsWire • 09/15/20
Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 09/10/20
Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 09/01/20
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent DevelopmentsGlobeNewsWire • 09/01/20
Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral AntibodyGlobeNewsWire • 08/26/20
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020GlobeNewsWire • 08/25/20
Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001GlobeNewsWire • 08/06/20
Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing and Drug Product Parenteral ManufacturingGlobeNewsWire • 07/28/20